Foundations Investment Advisors LLC reduced its holdings in Intuitive Surgical by 93.3% during the third quarter, selling 37,895 shares and retaining 2,715 shares. The remaining position was valued at approximately $1.21 million as of the most recent SEC filing, marking a significant shift in the firm’s exposure to the surgical robotics leader.

Several other asset managers increased their stakes in Intuitive Surgical during the same period. Strategic Advisors LLC added 4,031 shares for a 63.3% boost, ending the quarter with 10,397 shares valued at $4.65 million. AE Wealth Management raised its position by 18.9% to 11,556 shares ($5.17 million), while LRI Investments lifted its stake by 24.0% to 1,997 shares ($893,000). Birchbrook Inc. and Activest Wealth Management also increased holdings by 5.1% and 21.7%, respectively. Institutional and hedge fund ownership now represents more than 83% of the company’s outstanding shares.

Research coverage remains overwhelmingly positive, with two analysts assigning Strong Buy ratings, fourteen issuing Buy recommendations, eight maintaining Hold ratings and one issuing a Sell. The consensus target price across all reports stands at $620.41, reflecting a Moderate Buy consensus and a broad expectation for continued growth in Intuitive Surgical’s surgical robotics franchise.

For the quarter ending January, Intuitive Surgical reported earnings per share of $2.53, exceeding consensus estimates by $0.26, and revenues of $2.87 billion, topping forecasts by $150 million and rising 18.8% year-over-year. The company posted a net margin of 28.38% and return on equity of 15.06%. Analysts forecast full-year EPS of 6.43, underlining confidence in sustained revenue growth driven by continued adoption of the da Vinci platform.